Transcatheter aortic valve replacement (TAVR), also known as transcatheter aortic valve implantation (TAVI), is a less invasive alternative to traditional open-heart surgery for patients with severe aortic valve stenosis, a condition characterized by the narrowing of the aortic valve opening. During TAVR, a new artificial valve is inserted via a catheter and positioned within the diseased valve, restoring normal blood flow through the aorta.
Once again in 2024, UTHealth Houston’s TAVR program has received the highest rating (3-star) from the Society of Thoracic Surgeons/American College of Cardiology. Our program is the highest rated STS/ACC TAVR program in Houston.
TAVR is primarily used to treat severe aortic valve stenosis when patients are deemed high risk or inoperable for traditional open-heart surgery. It may also be considered for intermediate-risk patients in certain cases. The procedure provides an effective means of improving symptoms, reducing mortality rates, and enhancing overall quality of life for patients with aortic valve disease.
Before undergoing TAVR, a comprehensive evaluation is conducted to assess the patient’s overall health and determine their suitability for the procedure. This evaluation may involve medical history review, physical examinations, blood tests, electrocardiogram (ECG), echocardiogram, and other imaging tests. The patient’s surgical risk is assessed, and a multidisciplinary heart team evaluates the need for TAVR versus other treatment options.
The TAVR procedure is typically performed in a specialized cardiac catheterization laboratory or hybrid operating room. The general steps involved in the procedure include:
After TAVR, the patient is transferred to the recovery area for monitoring and observation. The vital signs, heart function, and oxygenation are continuously monitored. Pain management, medication administration, and fluid balance are carefully managed. The patient may require a short stay in the intensive care unit (ICU) before being transferred to a regular hospital room.
While TAVR is generally safe and well-tolerated, there are potential risks and complications associated with the procedure, including:
The recovery time after TAVR varies depending on the individual patient and their overall health. However, compared to traditional open-heart surgery, TAVR typically involves a shorter hospital stay, ranging from a few days to a week. Patients may experience a quicker recovery, with a gradual return to normal activities within a few weeks.
TAVR has demonstrated excellent outcomes in terms of improving symptoms, reducing mortality rates, and enhancing the quality of life for patients with severe aortic valve stenosis. Following the procedure, post-procedure care may include:
If you have specific concerns about a procedure or your health, please consult a physician.